Figure 3.

Evaluation of miR‐130b and miR‐21 as potential diagnostic biomarkers for HCC diagnosis. (a) Receiver operating characteristics (ROC) curves were drawn with the data of serum miR‐130b and miR‐21 levels from 46 HCC patients and 55 healthy controls. (b) ROC curve was drawn with the data of combined serum miR‐130b with miR‐21 for HCC diagnosis by using binary logistic regression analysis. The combination of miR‐130b and miR‐21 showed a higher positive diagnostic rate of HCC from healthy control than miR‐130b or miR‐21 diagnosis alone